跳至主要内容
临床试验/NCT07224542
NCT07224542Enrolling By Invitation不适用

Smart Soft Contact Lenses for Continuous 24-hour Monitoring of Intraocular Pressure in Glaucoma Care

Indiana University2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
120
试验地点
2
主要终点
Goldmann Applanation Intraocular Pressure

研究概览

简要总结

This study is exploring the effectiveness and safety of soft contact lenses with embedded sensors, called smart contact lenses. Smart contact lenses are used to measure the pressure inside the eye.

详细描述

Subjects first present for a single qualification visit (phase 1), then present for up to 3 short-term (~1 hour) in-clinic visits (phase 2), and finally have visits prior to and following a full day (phase 3). Efficacy outcomes of the smart contact lens are compared to standard clinical measures of eye pressure. Safety outcomes of the smart contact lens are compared to those of traditional soft contact lenses.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Glaucomatous Arm Inclusion Criteria
  • 22+ years of age
  • Able to wear soft contact lenses
  • Previously diagnosed, currently pharmaceutically treated Primary Open Angle Glaucoma (POAG)
  • Non-Glaucomatous (Healthy Older Adults) Arm Inclusion Criteria
  • 22+ years of age
  • Able to wear soft contact lenses
  • Without glaucomatous disease

排除标准

  • for all arms:
  • Unable to complete the study procedures
  • Ocular disease other than glaucoma (if applicable)
  • Significant acute or chronic medical, neurologic, or other illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study and/or is contradicted for soft contact lens or sensor lens use

结局指标

主要结局

Goldmann Applanation Intraocular Pressure

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

The IOP of participants will be measured with the Goldmann applanation tonometry (GAT) prior to and following device use, and in the contralateral eye during device use. A \>2 mmHg difference in is considered clinically significantly different.

I-Care Tonometry Intraocular Pressure

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

The I-Care (I-Care, Inc.) tonometry will also be evaluated during contralateral eye device use. A \>2 mmHg difference in is considered clinically significantly different.

Lens comfort

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

Participant-reported comfort will be assessed using a simple 100-point numeric scale where a rating of '100' represents extremely uncomfortable/intolerable and a rating of '1' perfectly comfortable/not noticeable at all. Comfort assessments will occur prior to, during, and following all device use to allow comparisons to typical or comparator devices. A 7-point difference in ratings is considered clinically significantly different.

Lens Fit

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

Lens fit will be measured with slit lamp during lens wear and graded using the Cornea and Contact Lens Research Unit (CCLRU) grading scale, which ranges from 0 to 4 with a rating of 0 representing an optimal outcome. A difference of 1.0 grading unit will be considered clinically significant.

Goldmann Applanation Intraocular Pressure

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

The IOP of participants will be measured with the Goldmann applanation tonometry (GAT) prior to and following device use, and in the contralateral eye during device use. A \>2 mmHg difference in is considered clinically significantly different.

I-Care Tonometry Intraocular Pressure

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

The I-Care (I-Care, Inc.) tonometry will also be evaluated during contralateral eye device use. A \>2 mmHg difference in is considered clinically significantly different.

Lens comfort

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

Participant-reported comfort will be assessed using a simple 100-point numeric scale where a rating of '100' represents extremely uncomfortable/intolerable and a rating of '1' perfectly comfortable/not noticeable at all. Comfort assessments will occur prior to, during, and following all device use to allow comparisons to typical or comparator devices. A 7-point difference in ratings is considered clinically significantly different.

Lens Fit

时间窗: Phase 2: 1 hour on 3 days Phase 3: Up to 14 hours on 3 days

Lens fit will be measured with slit lamp during lens wear and graded using the Cornea and Contact Lens Research Unit (CCLRU) grading scale, which ranges from 0 to 4 with a rating of 0 representing an optimal outcome. A difference of 1.0 grading unit will be considered clinically significant.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pete Kollbaum, OD, PhD

Associate Dean

Indiana University

研究点 (2)

Loading locations...

相似试验